EUROPIN, founded in 1997, is a well-known and respected market player in the attractive disposable injectable medical device market. The highly profitable company develops and manufactures pen cannulae and lancet needles – primarily for diabetology as well as blood collection. With a production plant in Slovakia and an annual capacity of more than one billion needles, it is one of Europe’s largest developer and manufacturer of medical needles. As EUROPIN operates in a growing medical market segment, the company is well positioned to benefit from this growth thanks to innovative and high-quality products.
DZ Bank AG advised the majority shareholders of EUROPIN Group on the sale of their majority to a German investment holding focused on small / medium sized transactions in the DACH region. The managing directors and two members of the founding family of EUROPIN will remain significant shareholders and support the company in the future as part of the management team.